CA Stock MarketDetailed Quotes

XTCY Xtacy Therapeutics Corp

Watchlist
  • 0.025
  • 0.0000.00%
15min DelayTrading Sep 23 12:09 ET
1.45MMarket Cap0.00P/E (TTM)

Xtacy Therapeutics Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-113.14%-77.44K
115.83%77.44K
0
81.07%-80.7K
30.69%-216.7K
589.29K
-435.92%-489.29K
260.99%36K
-333.02%-426.3K
-4,837.37%-312.63K
Net income from continuing operations
65.95%-123.42K
74.64%-65.73K
-68.69%-265.84K
62.01%-519.94K
130.87%259.31K
---362.52K
-146.29%-259.13K
62.79%-157.6K
61.81%-1.37M
65.94%-839.98K
Operating gains losses
----
----
----
-103.85%-23.29K
----
----
----
----
96.18%-11.43K
----
Other non cashItems
-101.99%-11.62K
---77.6K
--268.24K
-233.24%-400.88K
-1,491.98%-1.43M
--584.54K
----
----
18.16%300.87K
38.34%-90.1K
Change In working capital
265.85%135.04K
162.22%143.33K
-101.24%-2.4K
32.22%863.41K
56.09%981.6K
---81.42K
-461.64%-230.37K
589.19%193.6K
30.50%652.99K
74.08%628.87K
-Change in prepaid assets
----
----
----
193.70%279.08K
----
----
----
----
---297.83K
----
-Change in payables and accrued expense
----
----
----
-38.54%584.33K
----
----
----
----
90.01%950.82K
----
Cash from discontinued investing activities
Operating cash flow
--0
--0
--0
81.07%-80.7K
30.69%-216.7K
--140.6K
55.53%-40.6K
260.99%36K
-333.02%-426.3K
-4,837.37%-312.63K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
0
0
0
-79.86%80.7K
-27.94%216.7K
-140.6K
424.75%40.6K
-132.01%-36K
233.68%400.67K
300.72K
Net issuance payments of debt
--0
----
----
527.86%29.02K
--29.02K
---4.6K
----
----
-109.04%-6.78K
----
Net common stock issuance
----
----
----
--0
----
----
----
----
--407.45K
----
Net other financing activities
----
----
----
--51.68K
--187.68K
----
----
-132.01%-36K
----
----
Cash from discontinued financing activities
Financing cash flow
--0
--0
--0
-79.86%80.7K
-27.94%216.7K
---140.6K
424.75%40.6K
-132.01%-36K
233.68%400.67K
--300.72K
Net cash flow
Beginning cash position
--0
--0
--0
--0
--0
--0
--0
--0
540.86%25.63K
-62.71%11.92K
Current changes in cash
----
----
----
----
----
----
----
----
-218.49%-25.63K
-88.20%-11.92K
End cash Position
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Free cash from
--0
--0
--0
81.07%-80.7K
30.69%-216.7K
--140.6K
55.53%-40.6K
260.99%36K
-333.02%-426.3K
-4,837.37%-312.63K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -113.14%-77.44K115.83%77.44K081.07%-80.7K30.69%-216.7K589.29K-435.92%-489.29K260.99%36K-333.02%-426.3K-4,837.37%-312.63K
Net income from continuing operations 65.95%-123.42K74.64%-65.73K-68.69%-265.84K62.01%-519.94K130.87%259.31K---362.52K-146.29%-259.13K62.79%-157.6K61.81%-1.37M65.94%-839.98K
Operating gains losses -------------103.85%-23.29K----------------96.18%-11.43K----
Other non cashItems -101.99%-11.62K---77.6K--268.24K-233.24%-400.88K-1,491.98%-1.43M--584.54K--------18.16%300.87K38.34%-90.1K
Change In working capital 265.85%135.04K162.22%143.33K-101.24%-2.4K32.22%863.41K56.09%981.6K---81.42K-461.64%-230.37K589.19%193.6K30.50%652.99K74.08%628.87K
-Change in prepaid assets ------------193.70%279.08K-------------------297.83K----
-Change in payables and accrued expense -------------38.54%584.33K----------------90.01%950.82K----
Cash from discontinued investing activities
Operating cash flow --0--0--081.07%-80.7K30.69%-216.7K--140.6K55.53%-40.6K260.99%36K-333.02%-426.3K-4,837.37%-312.63K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 000-79.86%80.7K-27.94%216.7K-140.6K424.75%40.6K-132.01%-36K233.68%400.67K300.72K
Net issuance payments of debt --0--------527.86%29.02K--29.02K---4.6K---------109.04%-6.78K----
Net common stock issuance --------------0------------------407.45K----
Net other financing activities --------------51.68K--187.68K---------132.01%-36K--------
Cash from discontinued financing activities
Financing cash flow --0--0--0-79.86%80.7K-27.94%216.7K---140.6K424.75%40.6K-132.01%-36K233.68%400.67K--300.72K
Net cash flow
Beginning cash position --0--0--0--0--0--0--0--0540.86%25.63K-62.71%11.92K
Current changes in cash ---------------------------------218.49%-25.63K-88.20%-11.92K
End cash Position --0--0--0--0--0--0--0--0--0--0
Free cash from --0--0--081.07%-80.7K30.69%-216.7K--140.6K55.53%-40.6K260.99%36K-333.02%-426.3K-4,837.37%-312.63K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data